Causaly

Causaly is an artificial intelligence company for the life sciences. Founded in 2018, it builds a platform that combines machine learning with a high-precision biomedical knowledge graph to help pharmaceutical and biopharma researchers find, interpret and share evidence in drug discovery and R&D. The Causaly AI platform performs natural language processing over the scientific literature to retrieve information, reason about causal relationships and surface connections that are not readily apparent, and it automates complex research workflows across target identification and competitive intelligence.

The company's stated focus is on scaling scientific expertise: workflows that previously took scientists weeks are automated so that researchers can concentrate on higher-value work. Its technical domains span machine learning, natural language processing, data synthesis and analysis and causal reasoning applied to biomedical data. The stated goal is to bring life-changing treatments to patients faster.

Causaly works with some of the world's largest biopharma companies and is backed by investors including ICONIQ and Index Ventures. The company describes itself as built by people who understand both technology and biology, with an emphasis on ownership, curiosity and scientific rigor. It holds that AI for science should be transparent and evidence-backed, and describes a team that moves fast and ships confidently.